,
your personalized virtual assistant to find clinical trials. Go head, 
Laura E. Horvath
Central DuPage HospitalWinfield, Illinois - 60190 Central Dupage Cancer CenterWinfield, Illinois - 60190 (708-216-9000) |
- CLINICAL TRIALS 11
- CONDITIONS15
- INTERVENTIONS18
- SINCE2007
Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
March 2009 - September 2012
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
July 2009 - June 2012
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
April 2008 - January 2010
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB Recurrent or Persistent Cervical Cancer
April 2009 - December 2011
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II Stage III or Stage IV Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer
August 2009 - January 2016
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy Paclitaxel and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
March 2009 - March 2013
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage III or Stage IVA Endometrial Cancer
June 2009 - December 2013
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013
Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I Stage II or Stage IIIA Breast Cancer Undergoing Chemotherapy
September 2009 - January 2012
An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer
September 2008 - October 2014
Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer Primary Peritoneal Cavity Cancer or Fallopian Tube Cancer Undergoing Chemotherapy
September 2007 -
Breast Neoplasms
Lung Neoplasms
Ovarian Neoplasms
Fatigue
Carcinoma, Non-Small-Cell Lung
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Neurotoxicity Syndromes
Endometrial Neoplasms
Uterine Cervical Neoplasms
Recurrence
Peripheral Nervous System Diseases
Demyelinating Diseases
Polyneuropathies
Neurologic Manifestations
Placebo
Intensity-Modulated Radiation Therapy
Laboratory Biomarker Analysis
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Cyclophosphamide
Radiation Therapy
Doxorubicin Hydrochloride
Cetuximab
Morab-003 (Farletuzumab)
0.9% Saline
Topotecan Hydrochloride
Ac Regimen
Duloxetine Hydrochloride
Brachytherapy
Acetyl-L-Carnitine Hydrochloride
